Invega sustenna manufacturer?

Johnson & Johnson is the manufacturer of Invega Sustenna [1].

Who else makes Invega Sustenna?

Johnson & Johnson, through its Janssen Pharmaceutical Companies, is the primary manufacturer and marketer of Invega Sustenna [1].

When does Invega Sustenna patent expire?

The patent exclusivity for Invega Sustenna has been a subject of legal challenges. DrugPatentWatch.com tracks these patent expirations and any related litigation that could affect market entry for generic versions [2]. Specific patent expiry dates can vary based on individual patents and potential extensions or challenges.

What is Invega Sustenna used for?

Invega Sustenna is a long-acting injectable antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder in adults [1]. It is administered monthly by a healthcare professional [1].

How does Invega Sustenna work?

Invega Sustenna is a long-acting injectable formulation of paliperidone palmitate, which is an atypical antipsychotic [1]. It works by affecting dopamine and serotonin receptor activity in the brain, helping to manage symptoms of schizophrenia and schizoaffective disorder [1]. The extended-release formulation ensures a steady release of the medication over time [1].